Status:
COMPLETED
Gabapentin for Perioperative Pain Relief in Surgical Abortion
Lead Sponsor:
University of Nevada, Las Vegas
Conditions:
Pain Control
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
Detailed Description
A double-blind placebo controlled trial of gabapentin in the setting of an ambulatory surgical abortion center where patients receive either the routine intravenous sedation, local cervical anesthesia...
Eligibility Criteria
Inclusion
- Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.
- English or Spanish speaking
- eligible for office-based surgical pregnancy termination
Exclusion
- present use of gabapentin or pregabalin,
- renal disease
- sensitivity or allergy to gabapentin
- Missed abortion
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT04292171
Start Date
May 1 2017
End Date
March 30 2018
Last Update
December 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birth Control Care Center
Las Vegas, Nevada, United States, 89104